Drug Trial Radar · NCT01098357
Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
Last checked: Nov 20, 2026Latest source record: Dec 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
192
Actual
Start
Jun 2010
Primary completion
Feb 2011
Study completion Sep 2011
Sponsor
- Lead sponsor
- Virchow GroupIndustry
- Sponsor type
- Industry
- Collaborators
- Adocia
- First posted
- Apr 2, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, active-control, multicentre, parallel group, randomised and dose-finding efficacy and safety study. Compare the efficacy and safety of BioChaperone PDGF-BB applied at 12.5 µg/cm² every two days for up to 20 weeks to becaplermin gel (Regranex® Gel 0.01%) applied daily for up to 20 weeks for the treatment of neuropathic diabetic foot ulcer. Assess the effect of a double dose of BioChaperone PDGF-BB (25 µg/cm²) applied every two days for up to 20 weeks.
Conditions
- Diabetic Foot Ulcers
Interventions
Biochaperone PDGF-BB Low doseDrug
BioChaperone PDGF-BB low dose is applied as a spray every two days at the dose of 12.5 µg/cm2 for up to 20 weeks
Biochaperone PDGF-BB High doseDrug
BioChaperone PDGF-BB high dose is applied as a spray every two days at the dose of 25 µg/cm2 for up to 20 weeks
RegranexDrug
Regranex gel is applied once daily at the dose of 6.25 µg/cm2 for up to 20 weeks
Biochaperone PDGF-BB Very Low DoseDrug
BioChaperone PDGF-BB Very Low Dose sprayed on the wound every two days (e.g., Mondays, Wednesdays and Fridays) for 20 weeks or until complete wound healing, at the dose of 4 µg/cm²/application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of complete wound closureTime frame: 20 WEEKS
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Vijay Vachharajani Memorial
Rajkot, Gujarat, India
Jain Institute of Vascular sciences
Bangalore, Karnataka, India
Karnataka Institute of Diabetology
Bangalore, Karnataka, India
Lakeshore Hospital & Research Centre Ltd
Kochi, Kerala, India
Joshi Hospital , Maharashra Medical Foundation
Pune, Maharashtra, India
M.V. Hospital for Diabetes
Chennai, Tamil Nadu, India
S.K. Diabetes Research & Education Centre
Kolkata, West Bengal, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.